Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;3(1):39-56.
doi: 10.1159/000452341. Epub 2017 Feb 1.

Botulinum Toxin Off-Label Use in Dermatology: A Review

Anna Campanati  1 , Emanuela Martina  1 , Katia Giuliodori  1 , Veronica Consales  1 , Ivan Bobyr  1 , Annamaria Offidani  1
Affiliations
Review

Botulinum Toxin Off-Label Use in Dermatology: A Review

Anna Campanati et al. Skin Appendage Disord. 2017 Mar.

Abstract

Background: Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum which causes a flaccid muscle paralysis. It is currently used for aesthetic treatments and in the focal hyperhidrosis. Recently, botulinum toxin has also been used experimentally in many other dermatological conditions with good results.

Objective: To review and analyze the possible botulinum toxin off-label applications published.

Methods: A retrospective review of the published data was conducted.

Conclusions: this potent drug can lead to several off-label indications of interest for dermatologists. Further clinical trials are still needed to better understand the real efficacy and safety of these applications and to standardize injection and dose protocols.

Keywords: Botulinum toxin; Folds dermatitis; Hidradenitis suppurativa; Keloids; Off-label therapy.

PubMed Disclaimer

References

    1. Lowe NJ, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151:1115–1122. - PubMed
    1. Campanati A, Giuliodori K, Martina E, Giuliano A, Ganzetti G, Offidani A. Onabotulinumtoxin type A (Botox) versus incobotulinumtoxin type A (Xeomin) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial. J Neural Transm. 2014;121:21–26. - PubMed
    1. Campanati A, Giuliodori K, Giuliano A, Martina E, Ganzetti G, Marconi B, Chiarici A, Offidani A. Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach. Arch Dermatol Res. 2013;305:691–697. - PubMed
    1. Campanati A, Penna L, Gesuita R, Offidani A. Local neural block at the wrist for the treatment of palmar huperhidrosis with botulinum toxin: technical improvements. J Am Acad Dermatol. 2004;51:345–348. - PubMed
    1. Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A. Treatment of focal idiopathic hyperhidrosis with botulinum toxin type A: clinical predictive factors of relapse-free survival. J Eur Acad Dermatol Venereol. 2011;25:917–921. - PubMed